BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23510725)

  • 1. Biomarkers for immune intervention trials in type 1 diabetes.
    Mallone R; Roep BO
    Clin Immunol; 2013 Dec; 149(3):286-96. PubMed ID: 23510725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DiaPep277® and immune intervention for treatment of type 1 diabetes.
    Schloot NC; Cohen IR
    Clin Immunol; 2013 Dec; 149(3):307-16. PubMed ID: 24090708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease.
    Skog O; Korsgren S; Melhus A; Korsgren O
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):118-23. PubMed ID: 23422243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for success.
    Rekers NV; von Herrath MG; Wesley JD
    Clin Immunol; 2015 Nov; 161(1):37-43. PubMed ID: 26122172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3 clinical trials in type 1 diabetes mellitus.
    Daifotis AG; Koenig S; Chatenoud L; Herold KC
    Clin Immunol; 2013 Dec; 149(3):268-78. PubMed ID: 23726024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study.
    Speake C; Bahnson HT; Wesley JD; Perdue N; Friedrich D; Pham MN; Lanxon-Cookson E; Kwok WW; Sehested Hansen B; von Herrath M; Greenbaum CJ
    Front Immunol; 2019; 10():2023. PubMed ID: 31572352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on global intervention studies in type 1 diabetes.
    Chiang JL; Haller MJ; Schatz DA
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):695-712. PubMed ID: 23099265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy for type 1 diabetes mellitus (DM1)].
    van der Torren CR; Roep BO
    Ned Tijdschr Geneeskd; 2012; 156(15):A4268. PubMed ID: 22495007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.
    Schneider DA; Kretowicz AM; von Herrath MG
    Diabetes Obes Metab; 2013 Jul; 15(7):581-92. PubMed ID: 23194064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune intervention for type 1 diabetes mellitus.
    Skyler JS
    Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes: etiology, immunology, and therapeutic strategies.
    van Belle TL; Coppieters KT; von Herrath MG
    Physiol Rev; 2011 Jan; 91(1):79-118. PubMed ID: 21248163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention versus intervention of type 1 diabetes.
    Brooks-Worrell B; Palmer JP
    Clin Immunol; 2013 Dec; 149(3):332-8. PubMed ID: 23803322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune therapy and β-cell death in type 1 diabetes.
    Lebastchi J; Deng S; Lebastchi AH; Beshar I; Gitelman S; Willi S; Gottlieb P; Akirav EM; Bluestone JA; Herold KC
    Diabetes; 2013 May; 62(5):1676-80. PubMed ID: 23423576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
    Skyler JS
    Clin Pharmacol Ther; 2007 May; 81(5):768-71. PubMed ID: 17392722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M; Clark A
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.